In bladder cancer, ALDOA was reported (Li et al., 2019a) to act as an oncogene by interacting with E-cadherin-epidermal growth factor receptor (EGFR) signaling, leading to cancer cell metastasis. The gene discussed is EGFR; the disease is urinary bladder carcinoma.